First-Line Treatment for Impetigo in Patients with Amoxicillin Allergy
For patients with a history of amoxicillin allergy, the first-line treatment for impetigo is topical mupirocin or oral cephalosporins such as cefdinir, cefuroxime, or cefpodoxime. 1
Treatment Options Based on Allergy History
Topical Antibiotics
- Topical mupirocin is an excellent first-line option for patients with limited impetigo lesions and amoxicillin allergy 2, 3
- Topical antibiotics show better cure rates than placebo (pooled odds ratio 6.49) and have fewer systemic side effects than oral antibiotics 3
- Topical fusidic acid is an alternative with similar efficacy to mupirocin 3
Oral Antibiotics for Extensive Disease
For Non-Anaphylactic Amoxicillin Allergy:
- Cefdinir (14 mg/kg/day in 1 or 2 doses) is recommended as first-line oral therapy 1
- Cefuroxime (30 mg/kg/day in 2 divided doses) is an effective alternative 1
- Cefpodoxime (10 mg/kg/day in 2 divided doses) can also be used 1
For Anaphylactic Amoxicillin Allergy:
- Clindamycin (30-40 mg/kg/day in 3 divided doses) is recommended for patients with severe penicillin allergy 1
- Macrolides (erythromycin, azithromycin, clarithromycin) can be considered, though resistance rates to erythromycin are rising 2
Decision Algorithm Based on Disease Extent and Allergy Type
Limited disease (few lesions):
Extensive disease (multiple lesions) with non-anaphylactic amoxicillin allergy:
Extensive disease with history of anaphylaxis to amoxicillin:
Important Clinical Considerations
- Topical antibiotics may be superior to oral antibiotics for limited disease and have fewer side effects 2, 3
- Oral antibiotics should be reserved for patients with extensive disease or when topical therapy is impractical 2, 4
- Resistance patterns against antibiotics change and should be taken into account in the choice of therapy 3, 5
- Penicillin V is seldom effective for impetigo treatment 2
- Treatment helps relieve discomfort, improve cosmetic appearance, and prevent spread of organisms that may cause other illnesses 2
Cross-Reactivity Considerations
- Patients with non-severe penicillin allergy histories can safely receive cephalosporins with dissimilar R1 side chains 1
- The risk of cross-reactivity between penicillins and cephalosporins is very low (<5%) 1
- For patients with a history of anaphylaxis to penicillins, avoid cephalosporins and use alternative agents like clindamycin 1